Manabu Horii Selected Research

Manabu Horii Research Topics

Disease

9	Myocardial Infarction 06/2013 - 04/2006
7	Heart Failure 01/2018 - 09/2004
3	Acute Coronary Syndrome 01/2023 - 01/2011
3	Stroke (Strokes) 01/2023 - 06/2013
3	Atherosclerotic Plaque (Atheroma) 01/2020 - 12/2009
2	Chronic Renal Insufficiency 01/2022 - 06/2013
2	Fabry Disease (Fabry's Disease) 01/2019 - 12/2018
2	Hyperplasia 10/2008 - 09/2006
2	Infarction (Infarctions) 08/2007 - 04/2006
1	Supraventricular Tachycardia 01/2023
1	Bradycardia 01/2023
1	Ventricular Tachycardia 01/2023
1	Sarcopenia 01/2021
1	Takotsubo Cardiomyopathy 01/2018
1	Pulmonary Hypertension 01/2016
1	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 06/2015
1	Ischemic Stroke 04/2015
1	Brain Infarction 04/2015
1	Necrosis 01/2014
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2013
1	Fever (Fevers) 03/2012
1	Lacerations 01/2012
1	Pathologic Constriction (Stenosis) 01/2012
1	Hypertrophy 04/2010
1	Renal Insufficiency (Renal Failure) 12/2009
1	Atherosclerosis 12/2009
1	Thrombosis (Thrombus) 12/2009
1	Stable Angina 10/2008
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 09/2008
1	Neointima 09/2006
1	Neoplasms (Cancer) 07/2006
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2006

Drug/Important Bio-Agent (IBA)

5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2013 - 04/2006
3	Tyrosine (L-Tyrosine)FDA Link 01/2013 - 12/2009
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 01/2020
2	Indicators and Reagents (Reagents)IBA 01/2021 - 01/2013
2	Peptides (Polypeptides)IBA 06/2013 - 07/2007
2	Biomarkers (Surrogate Marker)IBA 06/2013 - 12/2009
2	LipidsIBA 01/2012 - 01/2011
2	CytokinesIBA 12/2009 - 10/2008
2	Natriuretic PeptidesIBA 07/2007 - 09/2004
2	AldosteroneIBA 07/2006 - 01/2006
1	omega-Chloroacetophenone (Mace)IBA 01/2021
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2020
1	Docosahexaenoic AcidsIBA 01/2020
1	Eicosapentaenoic AcidIBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	GlycosphingolipidsIBA 01/2019
1	GalactosidasesIBA 12/2018
1	GTP-Binding Proteins (G-Protein)IBA 01/2018
1	CatecholaminesIBA 01/2018
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2018
1	PlasminogenIBA 01/2016
1	Fibrinogen (Factor I)FDA Link 01/2016
1	DiureticsIBA 06/2015
1	Tolvaptan FDA Link 06/2015
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 04/2015
1	Angiotensin Receptor AntagonistsIBA 04/2015
1	C-Reactive ProteinIBA 03/2012
1	Rosuvastatin Calcium (Crestor)FDA Link 01/2011
1	Brain Natriuretic Peptide (Natrecor)FDA Link 04/2010
1	ApolipoproteinsIBA 12/2009
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2009
1	Sirolimus (Rapamycin)FDA Link 10/2008
1	MetalsIBA 10/2008
1	3-Iodobenzylguanidine (Iobenguane)IBA 09/2008
1	Proteins (Proteins, Gene)FDA Link 09/2008
1	von Willebrand FactorIBA 09/2008
1	technetium tc-99m tetrofosmin (Myoview)FDA Link 08/2007
1	Atrial Natriuretic Factor (ANF)IBA 07/2007
1	InterleukinsIBA 09/2006
1	Pentoxifylline (Trental)FDA LinkGeneric 09/2006
1	Messenger RNA (mRNA)IBA 09/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2006
1	efonidipineIBA 07/2006
1	Angiotensin IIIBA 07/2006
1	Nifedipine (Adalat)FDA LinkGeneric 07/2006
1	RNA (Ribonucleic Acid)IBA 04/2006
1	salicylhydroxamic acid (SHAM)IBA 04/2006

Therapy/Procedure

4	Therapeutics 01/2023 - 12/2009
2	Percutaneous Coronary Intervention 01/2012 - 09/2006
2	Stents 12/2009 - 10/2008
1	Patient Readmission 01/2023
1	Enzyme Replacement Therapy 01/2019
1	Secondary Prevention 04/2015
1	Hemodiafiltration 01/2014
1	Renal Dialysis (Hemodialysis) 06/2013
1	Intravenous Injections 12/2012
1	Drug-Eluting Stents 12/2009
1	Cell- and Tissue-Based Therapy (Cell Therapy) 08/2007
1	Transplantation 08/2007